P681: Impact of Crohn’s disease on survival in Korean patients with small bowel adenocarcinomaECCO'22Year: 2022
Authors: Kim, K.(1);Choi, K.(2);Hwang, S.W.(1);Im, J.P.(2);Ye, B.D.(1);Kim, J.S.(2);Yang, S.K.(1);Koh, S.J.(2);Park, S.H.(1);
(1)University of Ulsan College of Medicine- Asan Medical Center, Department of gastroenterology, Seoul, Korea- Republic Of;(2)Seoul National University College of Medicine, Department of Internal Medicine and Liver Research Institute, Seoul, Korea- Republic Of;
P682: Predictors of response to biologics in Ulcerative Colitis: A population-based study from the epi-IIRNECCO'22Year: 2022
Authors: Atia, O.(1); Lujan, R.(1); Greenfeld, S.(2); Kariv, R.(2); Matz, E.(3); Dotan, I.(4); Nevo, D.(5);Turner, D.(1);
(1)Shaare Zedek Medical Center- The Hebrew University of Jerusalem- Israel., Juliet Keidan Institute of Pediatric Gastroenterology Hepatology and Nutrition, Jerusalem, Israel;(2)Maccabi Health Services and the Sackler Faculty of Medicine- Tel Aviv University- Israel., Maccabi Health Services, Tel-Aviv, Israel;(3)Leumit Health Services, Leumit Health Services, Tel-Aviv, Israel;(4)Rabin Medical Center and the Sackler Faculty of Medicine- Tel Aviv University- Israel., Division of Gastroenterology, Petah Tikva, Israel;(5)Tel Aviv University- Israel, Department of Statistics and Operations Research- Tel Aviv University- Israel, Tel Aviv, Israel;
P683: Discontinuation of infliximab treatment: a comparison between IBD patients who retransitioned to originator and those who remained on biosimilarECCO'22Year: 2022
Authors: Meijboom, R.(1);Gardarsdottir, H.(2);Becker, M.(1);Movig, K.(3);Egberts, T.(2);Giezen, T.(1);
(1)Pharmacy Foundation of Haarlem Hospitals- Haarlem- the Netherlands, Pharmacy Foundation of Haarlem Hospitals- Haarlem- the Netherlands, Haarlem, The Netherlands;(2)Utrecht Institute for Pharmaceutical Sciences, Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht, The Netherlands;(3)Medisch Spectrum Twente, Department of Clinical Pharmacy, Enschede, The Netherlands;
P684: Increased risk of cardiovascular disease and high risk profiles compatible with metabolic syndrome in patients with Inflammatory Bowel Disease: a cross-sectional analysis of matched cohortsECCO'22Year: 2022
Authors: SleutjesAM, J.(1);Roeters van Lennep, J.E.(2);Kavousi, M.(3);Aribas, E.(3);van der Woude, C.J.(4);de Vries, A.C.(4);
(1)Erasmus Medical Centre, Gastroenterology & Hepatology, Rotterdam, The Netherlands;(2)Erasmus Medical Center, Internal Medicine, Rotterdam, The Netherlands;(3)Erasmus Medical Center, Epidemiology of Cardiometabolic Disorders, Rotterdam, The Netherlands;(4)Erasmus Medical Center, Gastroenterology & Hepatology, Rotterdam, The Netherlands;
P685: Strong Response to SARS-CoV-2 Vaccine Additional Doses among Patients with Inflammatory Bowel DiseasesECCO'22Year: 2022
Authors: Kappelman, M.(1);Weaver, K.(2);Zhang, X.(1);Chun, K.(3);Long, M.(2);
(1)University of North Carolina, Division of Pediatric Gastroenterology- Department of Pediatrics, Chapel Hill, United States;(2)University of North Carolina, Medicine, Chapel Hill, United States;(3)Labcorp, Esoterix, Calabasas, United States;PREVENT-COVID Study Group
P686: Outcomes of COVID-19 among patients with inflammatory bowel diseases and the influence of IBD-related medications– A Danish prospective population-based cohort studyECCO'22Year: 2022
Authors: Attauabi, M.(1,2,3);Dahlerup, J.F.(4);Poulsen, A.(5);Rosager Hansen, M.(6);Vester-Andersen, M.K.(7);Eraslan, S.(3);Prahm, A.P.(5);Pedersen, N.(8);Larsen, L.(9);Jess, T.(9,10);Neumann, A.(11);Haderslev, K.V.(12);Molazahi, A.(13);Lødrup, A.B.(14);Glerup, H.(15);Oppfeldt, A.M.(16);Jensen, M.D.(17);Theede, K.(1,2);Kiszka-Kanowitz, M.(1,2);Seidelin, J.B.(3);Burisch, J.(1,2);
(1)Copenhagen University Hospital- Hvidovre, Gastrounit- Medical Section, Hvidovre, Denmark;(2)University of Copenhagen- Hvidovre Hospital, Copenhagen Center for Inflammatory Bowel Disease in Children- Adolescents and Adults, Hvidovre, Denmark;(3)Herlev Hospital- University of Copenhagen, Department of Gastroenterology and Hepatology, Herlev, Denmark;(4)Aarhus University Hospital, Department of Hepatology and Gastroenterology, Aarhus, Denmark;(5)Bispebjerg University Hospital, Digestive Disease Center, Copenhagen, Denmark;(6)North Zealand University Hospital, Department of Gastroenterology, Frederikssund, Denmark;(7)Zealand University Hospital, Department of Internal Medicine, Koege, Denmark;(8)Slagelse Sygehus, Department of Gastroenterology, Slagelse, Denmark;(9)Aalborg University Hospital, Department of Gastroenterology and Hepatology, Aalborg, Denmark;(10)Aalborg University Hospital, National Center of Excellence for Molecular Prediction of Inflammatory Bowel Disease PREDICT- Department of Clinical Medicine, Aalborg, Denmark;(11)Region Hospital Viborg, Department of Internal Medicine, Viborg, Denmark;(12)Rigshospitalet- Copenhagen University Hospital, Department of Gastroenterology, Copenhagen, Denmark;(13)Holbaek Hospital, Department of Internal Medicine, Holbaek, Denmark;(14)Region Hospital West Jutland- Herning, Department of Internal Medicine, Herning, Denmark;(15)Region Hospital Silkeborg, Department of Internal Medicine, Silkeborg, Denmark;(16)Region Hospital Horsens, Department of Internal Medicine, Horsens, Denmark;(17)Lillebaelt Hospital- Vejle, Department of Internal Medicine- Section of Gastroenterology, Vejle, Denmark;Danish COVID-IBD Study Group
P687: Prevalence of iron deficiency and anaemia in the outpatient Inflammatory Bowel Disease population: a Dutch national cross-sectional studyECCO'22Year: 2022
Authors: Loveikyte, R.(1,2);Boer, M.(1);van der Meulen, C.N.(1);ter Steege, R.W.F.(3);Tack, G.(4);Kuyvenhoven, J.(5);Jharap, B.(6);Vu, M.K.(7);Vogelaar, L.(8);West, R.L.(9);van der Marel, S.(10);Römkens, T.(11);Mujagic, Z.(12);Hoentjen, F.(13,14);van Bodegraven, A.A.(15);van Schaik, F.D.M.(16);de Vries, A.C.(17);Dijkstra, G.(2);van der Meulen-de Jong, A.E.(1);
(1)Leiden University Medical Center, Department of Gastroenterology and Hepatology, Leiden, The Netherlands;(2)University Medical Center Groningen, Department of Gastroenterology and Hepatology, Groningen, The Netherlands;(3)Martini Hospital, Department of Gastroenterology and Hepatology, Groningen, The Netherlands;(4)Medical Centre Leeuwarden, Department of Gastroenterology and Hepatology, Leeuwarden, The Netherlands;(5)Spaarne Gasthuis Hospital, Department of Gastroenterology and Hepatology, Haarlem, The Netherlands;(6)Meander Medical Centre, Department of Gastroenterology and Hepatology, Amersfoort, The Netherlands;(7)Alrijne Hospital, Department of Gastroenterology and Hepatology, Leiderdorp, The Netherlands;(8)Diakonessenhuis Hospital, Department of Gastroenterology and Hepatology, Utrecht, The Netherlands;(9)Franciscus Gasthuis & Vlietland Hospital, Department of Gastroenterology and Hepatology, Rotterdam, The Netherlands;(10)Haaglanden Medical Centre, Department of Gastroenterology and Hepatology, The Hague, The Netherlands;(11)Jeroen Bosch Hospital, Department of Gastroenterology and Hepatology, Den Bosch, The Netherlands;(12)Maastricht University Medical Center+, Department of Gastroenterology and Hepatology, Maastricht, The Netherlands;(13)University of Alberta, Division of Gastroenterology, Edmonton, Canada;(14)Radboud University Medical Center, Department of Gastroenterology and Hepatology, Nijmegen, The Netherlands;(15)Zuyderland Medical Centre, Department of Gastroenterology and Hepatology, Heerlen-Sittard-Geleen, The Netherlands;(16)University Medical Center Utrecht, Department of Gastroenterology and Hepatology, Utrecht, The Netherlands;(17)Erasmus University Medical Centre, Department of Gastroenterology and Hepatology, Rotterdam, The Netherlands;on behalf of the Dutch Initiative on Crohn and Colitis (ICC)
P688: Sex difference in inflammatory bowel disease patients regarding depression: a nationwide population based study in KoreaECCO'22Year: 2022
Authors: Moon, J.M.(1);Han, K.(2);Shin, S.Y.(1);Choi, C.H.(1);Kim, J.S.(3);
(1)Chung-Ang University College of Medicine, Department of Internal Medicine, Seoul, Korea- Republic Of;(2)Soongsil University, Department of Statistics and Actuarial Science, Seoul, Korea- Republic Of;(3)Seoul National University College of Medicine, Department of Internal Medicine- Liver Research Institute, Seoul, Korea- Republic Of;
P689: Multicenter, cross-sectional, observational study on Epstein–Barr viral infection status and thiopurine use by age group in patients with inflammatory bowel disease in JapanECCO'22Year: 2022
Authors: Miura, M.(1);Shimizu, H.(2);Saito, D.(1);Miyoshi, J.(1);Matsuura, M.(1);Kudo, T.(3);Hirayama, D.(4);Yoshida, M.(5);Arai, K.(2);Iwama, I.(5);Nakase, H.(4);Shimizu, T.(3);Hisamatsu, T.(1);
(1)Kyorin University School of Medicine, Department of Gastroenterology and Hepatology, Tokyo, Japan;(2)National Center for Child Health and Development, Division of Gastroenterology, Tokyo, Japan;(3)Juntendo University Faculty of Medicine, Department of Pediatrics, Tokyo, Japan;(4)Sapporo Medical University School of Medicine, Department of Gastroenterology and Hepatology, Sapporo, Japan;(5)Saitama Children’s Medical Center, Division of Gastroenterology and Hepatology, Saitama, Japan;
P690: Rates of IBD in New Zealand Māori population at Lakes District Health Board: low but increasingECCO'22Year: 2022
Authors: Qiu, M.(1);Patel, R.N.(2);Gearry, R.B.(3,4);
(1)University of Auckland, School of Medicine, Auckland, New Zealand;(2)Lakes District Health Board, Gastroenterology, Rotorua, New Zealand;(3)Canterbury District Health Board, Gastroenterology, Christchurch, New Zealand;(4)University of Otago, Department of Medicine, Christchurch, New Zealand;
P691: Influence of ethnicity on the phenotype and clinical outcomes in Inflammatory Bowel Disease; comparison of a South American with a North American population.ECCO'22Year: 2022
Authors: Pérez, T.(1);Pizarro, B.(2); Ascui, G.(3);Tobar, F.(4);Cerda-Villablanca, M.(5);Alvares, D.(6);Orellana, M.(7);De la Vega, A.(8);Canistra, M.(9);Cornejo, B.(9);Baez, P.(10);Silva, V.(2);Arriagada, E.(8);Estela, R.(2);Hernandez-Rocha, C.(11);Alvarez-Lobos, M.(12);Rivera-Nieves, J.(13);
(1)Pontificia Universidad Catolica/Hospital San Borja-Arriaran, Department of Gastroenterology, Región Metropolitana, Chile;(2)Universidad de Chile, Medicina, Santiago, Chile;(3)Universidad de California San Diego, Inmunología, San Diego, United States;(4)Universidad de Chile, Department of Mathematical Engineering, Santiago, Chile;(5)Universidad de Chile, Center for Mathematical Modeling- Universidad de Chile, Santiago, Chile;(6)Pontificia Universidad Católica de Chile, Department of Statistics- Santiago- Chile, Santiago, Chile;(7)Universidad de Chile, Facultad De Ingenieria, Santiago, Chile;(8)Universidad De Chile, Gastroenterologia, Santiago, Chile;(9)Pontificia Universidad Católica de Chile, Medicina, Santiago, Chile;(10)Universidad de Chile, Centro de Informatica Medica y Telemedicina, Santiago, Chile;(11)Pontificia Universidad Católica de Chile, Gastroenterologia, Santiago, Chile;(12)Pontificia Universidad Católica de Chile, Gastroenterología, Santiago, Chile;(13)Universidad de California San Diego, Inflammatory Bowel Disease Center- Division of Gastroenterology- University of California- San Diego- La Jolla- CA- United States., San Diego, United States;Tamara Pérez-Jeldres1a 2 MD Benjamín Pizarro MD3 Felipe Tobar PhD3c Matías Orellana BSc3 Mauricio Cerda-Villablanca PhD3d Danilo Alves PhD1b Andrés de la Vega MD2 Macarena Canistra Bsc1 Bárbara Cornejo BSc1 Pablo Baéz PhD3e Verónica Silva MD2 Elizabeth Arriagada MD2 Ricardo Estela MD2 Gabriel Ascui Bsc4 Cristián Hernández-Rocha MD1a Manuel Álvarez Lobos MD1a Jesús Rivera-Nieves MD. 1 Universidad Católica de Chile Santiago Chile.a Division of Gastroenterology School of Medicine.b Division of Statistic School of Mathematics. 2 Instituto Chileno-Japonés Santiago Chile. 3 Universidad de Chile Santiago Chile. cDivision of Radiology School of Medicine. d Department of Mathematical Engineering. e Center for Mathematical Modeling Universidad de Chile 4 La Jolla Institute for Allergy and Immunology San Diego CA United States. 5 Inflammatory Bowel Disease Center Division of Gastroenterology University of California San Diego La Jolla CA United States.
P692: Clinical, therapeutic and evolutionary profile of fistulizing ano-perineal lesions in Crohn's diseaseECCO'22Year: 2022
Authors: Hassine, H.(1);KAHLAOUI, F.(1);Mtir, M.(1);Cherif, D.(1);Tlili, R.(1);Kchir, H.(1);Maamouri, N.(1);
(1)Rabta Hospital, Gastroenterology, Tunis, Tunisia;
P693: Willingness and hesitancy to the telemedicine in patients with inflammatory bowel disease during COVID-19 outbreak. Preliminary results of a survey in an Italian IBD CenterECCO'22Year: 2022
Authors: Bossa, F.(1);Guerra, M.(1);Carparelli, S.(1);Antonella, M.(1);Terracciano, F.(1);Costantino, A.(2);Caprioli, F.(2);Valvano, M.R.(1);Martino, G.(1);Nardella, M.(1);Perri, F.(1);
(1)Fondazione Casa Sollievo della Sofferenza, Gastroenterology, San Giovanni Rotondo, Italy;(2)Fondazione Ca' Grande Ospedale Maggiore Policlinico di Milano, Gastroenterology and Digestive Endoscopy, Milano, Italy;
P694: COVID-19 vaccination rate and willingness of an additional dose among inflammatory bowel disease patients receiving biologic therapy.ECCO'22Year: 2022
Authors: Ramos Lopez, L.(1);Carrillo-Palau, M.(1);Alonso-Abreu , I.(1);Reygosa, C.(1);Hernández-Buylla, N.(1);Amaral , C.(1);Hernández, A.(1);Benítez-Zafra, F.(1);Pérez-González, F.(1);Quintana-Díaz, H.(1);Hernández-Guerra, M.(1);
(1)Hospital Universitario De Canarias, Department of Gastroenterology, Santa Cruz De Tenerife, Spain;
P696: Genetic predisposition to infliximab immunogenicity in patients with immune-mediated inflammatory diseases – secondary analyses from a randomised clinical trialECCO'22Year: 2022
Authors: Bjørlykke, K.(1,2);Brun, M.K.(2,3);Viken, M.K.(4,5);Stenvik, G.E.(3);Klaasen, R.A.(6);Gehin, J.E.(2,6);Warren, D.J.(6);Sexton, J.(3);Haavardsholm, E.A.(2,3);Jahnsen, J.(1,2);Lie, B.A.(2,4,5);Goll, G.L.(3);Bolstad, N.(6);Syversen, S.W.(3);Jørgensen, K.K.(1);
(1)Akershus University Hospital, Department of Gastroenterology, Lørenskog, Norway;(2)University of Oslo, Institute of Clinical Medicine, Oslo, Norway;(3)Diakonhjemmet Hospital, Division of Rheumatology and Research, Oslo, Norway;(4)Oslo University Hospital, Department of Medical Genetics, Oslo, Norway;(5)Oslo University Hospital, Department of Immunology, Oslo, Norway;(6)Oslo University Hospital, Department of Medical Biochemistry, Oslo, Norway;
P697: Examining the regulatory role of epigenetic and transcriptomic alterations in anti-TNF treatment response and disease progression in patients with Ulcerative ColitisECCO'22Year: 2022
Authors: Lawal, O.(1);Stack, R.(2);Ciara, E.(2);Tosetto, M.(2);McDonnell, C.(1);Rodriguez-Sosa, A.(1);Yochum, G.(3);Koltun, W.(3);Boland, K.(4);Sheahan, K.(5);Doherty, G.(2);Das, S.(1);
(1)Royal College of Surgeons in Ireland, School of Pharmacy and Biomolecular Sciences, Dublin, Ireland;(2)St. Vincents University Hospital, University College Dublin- Center for Colorectal Disease, Dublin, Ireland;(3)Penn State University, College of Medicine, Pennsylvania, United States;(4)Beaumont Hospital, Gastroenterology, Dublin, Ireland;(5)St. Vincents University Hospital, Department of Pathology and Center for Colorectal Disease- University College Dublin, Dublin, Ireland;
P698: Mapping field cancerisation and clonal evolution in IBD colons with dysplasia and colorectal cancerECCO'22Year: 2022
Authors: Yalchin, M.(1);Curtius, K.(2);Nowinski, S.(3);Moorghen, M.(1);Kimberley, C.(3);Smith, K.(3);Baker, A.M.(3);Al-Bakir, I.(3);Mossner, M.(3);Nadhamuni, V.(3);Hart, A.(1);Graham, T.(3);
(1)St. Mark’s Hospital- Inflammatory Bowel Disease Department- Watford Rd- Harrow HA1 3UJ., Inflammatory Bowel Disease Department, London, United Kingdom;(2)Division of Biomedical Informatics- Department of Medicine- University of California San Diego- La Jolla- CA USA, Division of Biomedical Informatics, San Diego, United States;(3)Centre for Genomics and Computational Biology- Barts Cancer Institute- Barts and the London School of Medicine and Dentistry- Queen Mary University of London- Charterhouse Sq- EC1M 6BQ- UK, Centre for Genomics and Computational Biology, London, United Kingdom;
P699: Machine Learning-based Prediction for Early Progression in Korean Crohn’s disease: Results from the IMPACT StudyECCO'22Year: 2022
Authors: Chun, J.(1);Suji, K.(2);Kwang Sung, A.(3);Soo Kyung, P.(4);Sangsoo, K.(2);Dong Il, P.(4);
(1)Gangnam Severance Hospital- Yonsei University College of Medicine, Department of Internal Medicine, Seoul, Korea- Republic Of;(2)Soongsil University, Bioinformatics, Seoul, Korea- Republic Of;(3)Functional Genome Institute- PDXen Biosystems Inc., Genetics, Seoul, Korea- Republic Of;(4)Kangbuk Samsung Hospital- Sungkyunkwan University School of Medicine, Internal Medicine, Seoul, Korea- Republic Of;
P700: The GEM Project: Stool metabolomic profile is associated with microbiome risk score and with future onset of Crohn’s disease in healthy first-degree relativesECCO'22Year: 2022
Authors: Lee , S.H.(1);Raygoza Garay , J.A.(1);Turpin , W.(1);Smith , M.I.(1);Goethel , A.(1);Griffiths , A.(2);Moayyedi , P.(3);Espin-Garcia , O.(4);Abreu , M.(5);Aumais , G.(6);Bernstein , C.N.(7);Biron , I.(8);Cino , M.(9);Deslandres , C.(10);Dotan , I.(8);El-Matary , W.(11);Feagan , B.(12);Guttman , D.(13);Huynh , H.(14);Hyams , J.(15);Jacobson , K.(16);Mack , D.(17);Marshall , J.(3);Otley , A.(18);Panaccione , R.(19);Ropeleski , M.(20);Silverberg , M.S.(1);Steinhart , A.H.(1);Turner , D.(21);Yerushalmi , B.(22);Xu , W.(4);Croitoru , K.(1);
(1)Mount Sinai Hospital- University of Toronto, Division of Gastroenterology, Toronto, Canada;(2)The Hospital for Sick Children, Division of Gastroenterology, Toronto, Canada;(3)McMaster University- Farncombe Family Digestive Health Research Institute, Department of Medicine, Hamilton, Canada;(4)Dalla Lana School of Public Health- University of Toronto, Division of Biostatistics, Toronto, Canada;(5)Department of Medicine- University of Miami- Miller School of Medicine, Division of Gastroenterology, Miami, United States;(6)Hopital Maisonneuve-Rosemont, Department of Gastroenterology, Montreal, Canada;(7)University of Manitoba, Inflammatory Bowel Disease Clinical and Research Centre, Winnipeg, Canada;(8)Rabin Medical Center, Division of Gastroenterology, Petah-Tikva, Israel;(9)University of Toronto, Division of Gastroenterology and Hepatology, Toronto, Canada;(10)CHU Sainte-Justine, Department of Gastroenterology, Montreal, Canada;(11)University of Manitoba, Pediatric Gastroenterology, Winnipeg, Canada;(12)University of Western Ontario, Departments of Medicine- Epidemiology- and Biostatistics, London, Canada;(13)University of Toronto, Centre for the Analysis of Genome Evolution and Function, Toronto, Canada;(14)University of Alberta, Department of Pediatrics, Edmonton, Canada;(15)Connecticut Children’s Medical Center, Division of Digestive Diseases- Hepatology- and Nutrition, Hartford, United States;(16)British Columbia Children's Hospital, Department of Pediatrics, Vancouver, Canada;(17)Children’s Hospital of Eastern Ontario and University of Ottawa, Division of Gastroenterology- Hepatology & Nutrition, Ottawa, Canada;(18)Izaak Walton Killam Hospital- Dalhousie University, Division of Gastroenterology, Halifax, Canada;(19)University of Calgary, Department of Gastroenterology, Calgary, Canada;(20)Queen's University, Gastrointestinal Diseases Research Unit- Department of Medicine, Kingston, Canada;(21)Shaare Zedek Medical Center- The Hebrew University of Jerusalem, The Juliet Keidan Institute of Pediatric Gastroenterology and Nutrition, Jerusalem, Israel;(22)Soroka University Medical Center and Faculty of Health Sciences- Ben-Gurion University of the Negev, Pediatric Gastroenterology Unit, Beer-Sheva, Israel;Crohn’s and Colitis Canada Genetics Environment Microbial Project Research Consortium